Company Filing History:
Years Active: 2021-2025
Title: Stanford L Peng: Innovator in Immunomodulatory Proteins
Introduction
Stanford L Peng is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of immunology. With a total of five patents to his name, he has made remarkable advancements in the development of immunomodulatory proteins.
Latest Patents
Among his latest patents are those related to April and BAFF inhibitory immunomodulatory proteins and methods of use thereof. These patents describe immunomodulatory proteins that exhibit neutralizing activity of BAFF and APRIL, or BAFF/APRIL heterotrimers. The proteins include variant domains of Transmembrane Activator and CAML Interactor (TACI), with TACI-Fc fusion proteins being a notable example. Additionally, the patents provide nucleic acid molecules encoding these immunomodulatory proteins, which have therapeutic utility for various immunological diseases, disorders, or conditions. The compositions and methods for making and using such proteins are also detailed in his patents.
Career Highlights
Stanford L Peng has worked with notable companies in the biotechnology sector, including Alpine Immune Sciences, Inc. and Seagen Inc. His work has significantly impacted the development of therapies for immunological conditions.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues such as Stacey R Dillon and Mark W Rixon, contributing to the advancement of immunological research and innovation.
Conclusion
Stanford L Peng's innovative work in immunomodulatory proteins showcases his dedication to advancing medical science. His patents and collaborations reflect his commitment to addressing critical immunological challenges.